Rheumatoid Arthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients should suffer from >=1 arthritis (joint pain with swelling) and ACPA-positive, but do not meet the classification criteria of 1987 ACR RA classification criteria nor the 2010 ACR/EULAR RA classification criteria or other RA classification criteria; 2) The duration of diseases should last 6 weeks to 6 months; 3) Patients should meet the criteria of the patent of spleen deficiency and blockage of wind and damp; 4) Patients aged 18 to 65 years; 5) Patients will be well informed and agree to participate in this study.
Exclusion criteria
Exclusion criteria: 1) Patients were treated with DMARDs or hydroxychloroquine within 2 months when agreeing to participate in this study; 2) Patients were treated with glucocorticoids; 3) Patients who suffer from severe organ disease or mental illness; 4) Patients who are allergic or have contraindications to the drugs involved in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RA transition rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patent scores;Simplified disease activity index, SDAI;patient's global assessment ofdisease activity, PGA;Clinical disease activity index, CDAI;physician's global assessment of disease activity, MDGA;Visual Analogue Scale/Score, VAS; | — |
Countries
China
Contacts
Zhejiang Chinese Medical University